...
首页> 外文期刊>Journal of Cancer Therapy >Salvage Photodynamic Therapy Is an Effective and Safe Treatment for Patients with Local Failure after Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
【24h】

Salvage Photodynamic Therapy Is an Effective and Safe Treatment for Patients with Local Failure after Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma

机译:挽救性光动力疗法是针对食管鳞状细胞癌的明确放化疗后局部衰竭患者的一种有效且安全的治疗方法

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Although chemoradiotherapy (CRT) is one curative treatment option for patients with esophageal squamous cell carcinoma (ESCC), local failure after CRT remains a major problem for patients’ curability. The aim of this study was to evaluate the efficacy and safety of photodynamic therapy (PDT) as a salvage treatment for local failure. From August 2007 to March 2012, 193 consecutive ESCC patients were treated with definitive CRT in Kyoto University Hospital. Eighteen of the patients with T2 or earlier T-stage local failure after CRT underwent salvage PDT. After the salvage PDT, 11 patients (61.1%) achieved a complete response at the primary site. Over a median follow-up period of 28.3 months, the 1-year survival and progression-free survival rates were 77.8% and 38.9%, respectively; and the 2-year survival and progression-free survival rates were 60.6% and 33.3%, respectively. Adverse events were mild esophageal stricture in seven (38.9%), esophageal obstruction because of necrotic tissue in nine (50.0%), and photosensitivity in three (16.7%) patients. There were no severe complications or treatment-related deaths. Salvage PDT may be a promising treatment option for the patients with a local residual or recurrent tumor after CRT for ESCC when the lesion is suspected to be in T2 or earlier.
机译:尽管放化疗是食管鳞状细胞癌(ESCC)患者的一种治疗选择,但放疗后局部失败仍然是患者治愈的主要问题。这项研究的目的是评估光动力疗法(PDT)作为局部失败的挽救性疗法的有效性和安全性。从2007年8月至2012年3月,京都大学医院连续193例ESCC患者接受了明确的CRT治疗。 CRT后有18位T2或更早的T期局部衰竭患者接受了挽救性PDT。抢救PDT后,有11名患者(61.1%)在原发部位获得了完全缓解。在28.3个月的中位随访期中,一年生存率和无进展生存率分别为77.8%和38.9%。 2年生存率和无进展生存率分别为60.6%和33.3%。不良事件为轻度食管狭窄7例(占38.9%),因坏死组织引起的食管阻塞9例(占50.0%)和三例患者的光敏性(占16.7%)。没有严重的并发症或与治疗有关的死亡。对于疑似在T2或更早的病变,在进行ESCC的CRT后出现局部残留或复发性肿瘤的患者,抢救PDT可能是一种有前途的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号